Virion Therapeutics to Speak at ACCESS ASIA Partnering Forum

September 25, 2025 (9:30 AM CST) — We’re pleased to announce that Dr. Sue Currie, Chief Operating Officer of Virion Therapeutics, will present at the ACCESS Asia Partnering Forum Online Showcase. ACCESS Asia builds on the success of ACCESS China, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and partners

About Virion Therapeutics

Virion Therapeutics, LLC is a clinical-stage biopharmaceutical company focused on T cell-based immunotherapies for chronic infectious diseases and cancer. Its platform centers on genetically encoded checkpoint modifiers, with VRON-0200 leading the pipeline and VRON-0300 advancing into oncology. The iterative scientific approach of the company is designed to produce novel, adaptable, and accessible disease-specific CD8+ T cell-based immunotherapies.

About the speaker

Dr. Sue Currie serves as Chief Operating Officer of Virion Therapeutics, LLC, where she and the Company continue to pursue a safe, convenient, accessible, and effective treatment for functional cure for chronic hepatitis B for the 300+ million persons affected by this disease. Virion’s platform technologies, and pipeline, that includes IND-enabling activities for their lead cancer program, offer a novel checkpoint modifier containing mechanism to help restore a patient’s own immune response against cancer and chronic infection.

Sue has 20+ years of strategic, clinical, and scientific leadership, not only within biotechnology and different pharm companies, but also in Veterans Health Administration, academic, correctional health, and community care settings. Additionally, Sue has authored numerous pivotal scientific publications in immuno-oncology and infectious diseases and is a Biotech Leader in the field.

About ACCESS ASIA Partnering Forum

ACCESS Asia Partnering Forum Online Showcase is scheduled to be held on September 25, 2025, 9:30 AM (China Standard Time) via Zoom.
This event will spotlight the 1st wave of 100 innovators, providing them with a global stage to showcase pipelines and connect with pharma, investors, and strategic partners worldwide.

Conference Name: ACCESS Asia Partnering Forum Online Showcase
Date & Time: September 25, 2025, 9:30 AM (China Standard Time)
View more information at: https://biotochina.org/